If you need more lookups,
subscriptions start at $34 USD/month.
Trine Østerbye Location
København, DK
Trine Østerbye Work
Chief Commercial Officer @ (April 2023 - Present)
Vice President, Kementec Solutions Inc. @ (March 2019 - April 2023)
Chief Commercial Officer @ (April 2018 - April 2023)
VP Global Sales @ (April 2017 - March 2018)
VP Biopharma Solutions @ (May 2016 - March 2017)
VP Sales and Marketing, Biomonitor @ (December 2015 - April 2016)
Sales Director, Biomonitor @ (November 2014 - November 2015)
VP Sales and Marketing @ (September 2013 - October 2014)
Sales and Marketing Manager @ (January 2005 - August 2013)
Scientific Project Coordinator @ (January 2003 - December 2005)
Product Developer @ (January 1999 - December 2003)
Trine Østerbye Education
INSEAD
Executive Management Programme (Business Administration and Management, General)
2022-2022
Københavns Universitet - University of Copenhagen
M.Sc. (Biochemistry)
1992-1999
Trine Østerbye Skills
Immunology
Lifesciences
ELISA
Biotechnology
Biochemistry
Cell Biology
Genomics
Cell
Hardware Diagnostics
Microbiology
Pharmaceutical Industry
Molecular Biology
Immunoassays
Cell Culture
Diagnostics
Product Marketing
Monoclonal Antibodies
Team Management
Business Development
Life Sciences
Medical Diagnostics
Medicinalindustrien
Medicinsk Udstyr
Produktlancering
Solutions
Medical Devices
Immunologi
Microsoft Dynamics CRM
Kommercialisering
Bioteknologi
Licensering
Biokemi
Biopharmaceuticals
Trine Østerbye Summary
Trine Østerbye, based in København, DK, is currently a Chief Commercial Officer at Samplix. Trine Østerbye brings experience from previous roles at Kementec Solutions A/S and Euro Diagnostica AB. Trine Østerbye holds a 2022 - 2022 Executive Management Programme in Business Administration and Management, General @ INSEAD. With a robust skill set that includes Immunology, Lifesciences, ELISA, Biotechnology, Biochemistry and more. Trine Østerbye has 1 emails on RocketReach.
Looking for a different Trine Østerbye?
Find contact details for 700 million professionals.